Pacira BioSciences (PCRX) Return on Capital Employed (2011 - 2026)
Pacira BioSciences (PCRX) posted quarterly Return on Capital Employed of 2.14% for Q1 2026, up 888.0% year-over-year from 0.22% in Q1 2025, and up 29.24% quarter-over-quarter from 1.65% in Q4 2025.
Pacira BioSciences (PCRX) Return on Capital Employed (2011 - 2026) Analysis & Trends
Pacira BioSciences' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 2.14% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 888.0% year-over-year to 2.14%; the TTM figure through Mar 2026 stood at 2.14% (up 888.0% YoY), while the FY2025 annual figure was 1.49%, up 734.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 2.14%, up from 1.65% in the prior quarter.
- The five-year high for Return on Capital Employed was 7.0% in Q1 2024, with the low at 8.35% in Q2 2025.
- The 5-year median for Return on Capital Employed is 3.17% (2025), against an average of 1.63%.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed plunged 1442 bps in 2025, then jumped 888 bps in 2026.
- Pacira BioSciences' Return on Capital Employed stood at 3.85% in 2022, then surged by 56 bps to 6.02% in 2023, then tumbled by 199 bps to 5.98% in 2024, then soared by 128 bps to 1.65% in 2025, then increased by 29 bps to 2.14% in 2026.
- Business Quant data shows PCRX's Return on Capital Employed at 2.14% in Q1 2026, 1.65% in Q4 2025, and 3.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 948.27 Mn | 697.24 Mn | 148.24 Mn | 1.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80% |
| Mar 31, 2026 | 2.14% |
| Dec 31, 2025 | 1.65% |
| Sep 30, 2025 | 3.17% |
| Jun 30, 2025 | -8.35% |
| Mar 31, 2025 | -6.74% |
| Dec 31, 2024 | -5.98% |
| Sep 30, 2024 | -5.08% |
| Jun 30, 2024 | 6.07% |
| Mar 31, 2024 | 7.00% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | 3.09% |
| Jun 30, 2023 | 3.38% |
| Mar 31, 2023 | 2.63% |
| Dec 31, 2022 | 3.85% |
| Sep 30, 2022 | 4.63% |
| Jun 30, 2022 | 5.02% |
| Mar 31, 2022 | 5.24% |
| Dec 31, 2021 | 7.53% |
| Sep 30, 2021 | 9.37% |